11.07.2015 Views

User Guide to Thresholds and Classification - Environmental ...

User Guide to Thresholds and Classification - Environmental ...

User Guide to Thresholds and Classification - Environmental ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

258<strong>User</strong> <strong>Guide</strong> for <strong>Thresholds</strong> <strong>and</strong> <strong>Classification</strong>sfor inhalation. This rule states essentially that the effective dose is directly proportional <strong>to</strong> the exposureconcentration <strong>and</strong> the duration of exposure.The assessment should be done on a case-by-case basis; for example, for a 28-day study the guidancevalues in Table 17.2 would be increased by a fac<strong>to</strong>r of three. Thus, for 6.9A <strong>and</strong> 6.9B classification,significant <strong>to</strong>xic effects observed in a 90-day repeated-dose study conducted in experimental animals <strong>and</strong>seen <strong>to</strong> occur at or below the (suggested) guidance values in the table would justify classification.Table 17.2: Guidance value ranges for repeated dose exposuresGuidance value ranges for categoryRoute of exposureUnits6.9A 6.9BOral (rat) mg/kg bw ≤10 >10–100Dermal (rat or rabbit) mg/kg bw ≤20 >20–200Inhalation (rat) gas ppm/6 hours/day ≤50 >50–250Inhalation (rat) vapour mg/L/6 hours/day ≤0.2 >0.2–1.0Inhalation (rat) dust, mist, fume mg/L/6 hours/day ≤0.02 >0.02–0.2Note: L = litre; mg/kg bw = milligrams per kilogram of bodyweight; mg/L = milligrams per litre; ppm = parts permillion.The values <strong>and</strong> ranges in Table 17.1 <strong>and</strong> Table 17.2 are intended <strong>to</strong> be only guides; that is, they are <strong>to</strong> beused as part of the weight-of-evidence approach, <strong>and</strong> <strong>to</strong> assist with decisions about classification. They arenot intended as strict demarcation values. These values are not no observed effect levels (NOELs), but arelowest observed adverse effect levels (LOAELs).It is feasible that a specific profile of <strong>to</strong>xicity is seen <strong>to</strong> occur in repeat-dose animal studies at a dose–concentration level below the guidance value (for example, < 100 mg/kg bw/day by the oral route). However,the nature of the effect (for example, nephro<strong>to</strong>xicity seen only in male rats of a particular strain known <strong>to</strong> besusceptible <strong>to</strong> this effect) may result in a decision not <strong>to</strong> classify. Conversely, a specific profile of <strong>to</strong>xicity maybe seen in animal studies occurring at above a guidance value (for example, at or above 100 mg/kg bw/dayby the oral route) <strong>and</strong> with supplementary information from other sources (for example, other long-termadministration studies or human case experience) supports a conclusion that, in view of the weight ofevidence, classification would be prudent.See Appendix 17B for converting a concentration of a substance in the diet (ppm) <strong>to</strong> a dietary intake (mg/kgbw/day).17.2.6. Study durationAs stated above, the use of fac<strong>to</strong>rs based on Haber‘s rule should take in<strong>to</strong> account rat studies of a durationshorter than 90 days (3 months). A similar approach should be taken in a weight-of-evidence approach whenJanuary 2012 EPA0109

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!